Tests:CA 15-3: Difference between revisions
- Department
- Biochemistry
Tests:CA 15-3
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
{| class="wikitable" | {| class="wikitable" | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Overview == | ||
|- | |- | ||
|Department | |Department | ||
| Line 19: | Line 19: | ||
CA153 | CA153 | ||
|- | |||
|Test Availability | |||
|Tuesdays and Friday | |||
Contact the laboratory if testing required urgently. | |||
|- | |- | ||
|Turnaround Time | |Turnaround Time | ||
| Line 27: | Line 31: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Specimen Requirements == | ||
|- | |- | ||
|Specimen Type | |Specimen Type | ||
|Plasma | |||
Serum | |||
|- | |||
|Specimen Transportation | |||
| | | | ||
|- | |- | ||
| Line 38: | Line 46: | ||
|SST <span style="background: #fbec5d"> Yellow-Top</span> | |SST <span style="background: #fbec5d"> Yellow-Top</span> | ||
|- | |- | ||
| | |Unacceptable | ||
| | | | ||
|- | |- | ||
| | |Paediatric Requirements | ||
|0.5 <span style="background:#e30022"> Red </span> microtainer | |0.5 <span style="background:#e30022"> Red </span> microtainer | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Aliquot Requirements == | ||
|- | |- | ||
|Sample Type | |Sample Type | ||
|>500 uL | |Serum | ||
|- | |||
|Preferred Volume | |||
|>500 uL | |||
|- | |- | ||
|Minimum Volume | |Minimum Volume | ||
|200 uL | |200 uL | ||
|- | |- | ||
|Aliquot Transportation | |Aliquot Transportation | ||
| Line 57: | Line 68: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Clinical Information == | ||
|- | |- | ||
|Reference Intervals | |Reference Intervals | ||
| Line 74: | Line 85: | ||
|- | |- | ||
! colspan="2" | | ! colspan="2" | | ||
== | == Comments == | ||
|- | |- | ||
| colspan="2" | | | colspan="2" |Ca 15-3 is particularly useful for monitoring breast cancer. | ||
Ca 15-3 is particularly useful for monitoring breast | |||
For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | ||
|} | |} | ||
Revision as of 15:36, 12 March 2025
Overview | |
|---|---|
| Department | Biochemistry |
| Test Code | CA153 |
| Synonyms | C153
C15-3 CA153 |
| Test Availability | Tuesdays and Friday
Contact the laboratory if testing required urgently. |
| Turnaround Time | 1 – 4 days |
| Stability – Add test | |
Specimen Requirements | |
| Specimen Type | Plasma
Serum |
| Specimen Transportation | |
| Preferred | 7mL Red-Top |
| Acceptable | SST Yellow-Top |
| Unacceptable | |
| Paediatric Requirements | 0.5 Red microtainer |
Aliquot Requirements | |
| Sample Type | Serum |
| Preferred Volume | >500 uL |
| Minimum Volume | 200 uL |
| Aliquot Transportation | Samples should be separated from red cells within 24hrs of collection. |
Clinical Information | |
| Reference Intervals | <30 U/mL |
| Test Method | Abbott Architect analyser using Abbott reagents.
CMIA method |
| Advanced Notice | |
| Patient Preparation | |
Comments | |
| Ca 15-3 is particularly useful for monitoring breast cancer.
For the serial monitoring of tumours, tumour markers should be tested in the same laboratory. | |